Department of Occupational Therapy, ESWOT Building, University of Texas Rio Grande Valley
Edinburg, Texas, 78539, United States
Location status: Recruiting
NCT Number: NCT07682753
The purpose of this project is to determine the feasibility and preliminary efficacy of a mental health skill-building and empowerment program (MH-POWER) for college students on the autism spectrum facing stress, anxiety, and depression. The program, grounded in cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and habit formation, will be implemented through weekly sessions and daily practice over 8 weeks. To evaluate the program's preliminary efficacy, we will measure mental health symptoms at baseline, mid-point, post-intervention, and one-month follow-up. Positive outcomes could lead to scalable interventions.
Interested in participating?
Request Info18 year–30 year
All sexes
Interventional
Not applicable
Edinburg, Texas, 78539, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The MH-POWER program is an 8-week, structured, and manualized program to improve mental health skills. The program design consists of weekly 60-minute group sessions (8-12 in each group) and daily structured practice activities to reinforce the skills learned in each session. Based on the Self-Regulation Framework, the MH-POWER program systematically integrates (a) CBT with a specific focus on cognitive restructuring and behavioral activation; (b) ACT with mindfulness, acceptance strategies, and values clarification; and (c) the science of habit formation, which includes action planning, goal setting, prompts, and self-monitoring. The program focuses on developing greater relationships between thoughts, emotions, and behaviors, as well as the ability to cope effectively. The focus areas of development include learning how thoughts create emotions and influence actions, developing a positive mindset, enhancing stress management and coping skills, employing structured problem
Time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress
Time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)
Each subscale yields a score between 20 and 80, with higher scores indicating greater severity of anxiety.
Time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)
Score ranges from 0-63. Higher scores indicate more severe depressive symptoms
Time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12).
Averaged scores of all items range from 1 to 7, a higher score indicates that the behavior functions as a strong, automatic habit
Time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12).
Scores range from 0 to 21, with higher scores indicating better quality of life
Contact information is provided by the study sponsor or research team.
University of Texas Rio Grande Valley
Other
Empowering Autistic College Students: Mental Health Skill Building at a Hispanic-Serving Institution
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07413874
Addison Disease, Adrenal Gland Diseases
Boone, North Carolina, United States
View Trial DetailsNCT07610473
Behavior, Behavioral Symptoms
Phoenix, Arizona, United States
View Trial DetailsNCT06877104
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05097586
Behavior, Behavioral Symptoms
Toronto, Ontario, Canada
View Trial Details